SCHEMBL6385807

SCHEMBL6385807

C#CCOc1cc(C(=O)O)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 3/20 0.47
ALB P02768 1/20 0.47
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
MRGPRX4 Q96LA9 3/20 0.44
PTGER1 P34995 1/20 0.43
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
TPMT P51580 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2283999 0.88 LMNA (0.57) LMNAMAPK1HTTRAB9AMRGPRX4
Hydrochloric Acid SCHEMBL4251669 0.86 LMNA (0.55) LMNAMAPK1HTTRAB9AMRGPRX4
SCHEMBL5762979 0.84 TTR (0.51) TTRMRGPRX4MEN1KMT2ACA12
SCHEMBL14638821 0.83 TSHR (0.43) LMNAHTTRAB9ATSHRMEN1
SCHEMBL26032958 0.81 MEN1 (0.47) HTTRAB9AMRGPRX4TSHRMEN1
SCHEMBL6388521 0.81 TSHR (0.49) LMNAHTTRAB9AMRGPRX4TSHR
SCHEMBL2286794 0.80 TSHR (0.68) TTRLMNAMAPK1HTTRAB9A
SCHEMBL27051562 0.80 RXRA (0.49) LMNAMAPK1HTTRAB9AMRGPRX4
Hydrochloric Acid SCHEMBL4252982 0.79 TSHR (0.66) TTRLMNAMAPK1HTTRAB9A
SCHEMBL1188710 0.79 TSHR (0.66) TTRALBLMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032873-A1 3-Amino chroman and 2-amino tetralin derivatives WYETH (US) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032873-A1 3-Amino chroman and 2-amino tetralin derivatives TPH2, HTR2C, HTR7 TTR 160/4885ALB 434/4885LMNA 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.